User menu

Treatment of Central Precocious Puberty With An Intranasal Analog of Gnrh (buserelin)

Bibliographic reference Bourguignon, JP. ; Vanvliet, G. ; Vandeweghe, M. ; Malvaux, Paul ; Vanderschuerenlodeweyckx, M. ; et. al. Treatment of Central Precocious Puberty With An Intranasal Analog of Gnrh (buserelin). In: European Journal of Pediatrics, Vol. 146, no. 6, p. 555-560 (1987)
Permanent URL http://hdl.handle.net/2078.1/53501
  1. Bayley N, Pinneau SR (1952) Tables predicting adult height from skeletal age: Revised for use with Greulich-Pyle hand standards. J Pediatr 40: 423–441
  2. Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E (1978) Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin releasing hormone. Science 202: 631–633
  3. Bierich JR (1975) Sexual precocity. Clin Endocrinol Metab 4: 107
  4. Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF, Crawford JD, Crowley WF (1986) Use of a potent, long-acting agonist of gonadotropin releasing hormone in the treatment of precocious puberty. Endocr Rev 7: 24–33
  5. Bourguignon JP, Burger HG, Franchimont P (1974) Radioimmunoassay of serum luteinizing hormone-releasing hormone (LH-RH) after intranasal administration and evaluation of the pituitary gonadotrophic response. Clin Endocrinol 3: 437–440
  6. Bourguignon JP, Vanderschueren-Lodeweyckx M, Malvaux P, Craen M, Du Caju MVL, Ernould C, Franchimont P (1982) Hypopituitarism and idiopathic delayed puberty: a longitudinal study in an attempt to diagnose gonadotropin deficiency before puberty. J Clin Endocrinol Metab 54: 733–744
  7. Bramley TA, Menzies GS, Baird DT (1985) Specific binding of gonadotropin releasing hormone and an agonist to human corpus luteum homogenates: characterization, properties and luteal phase levels. J Clin Endocrinol Metab 61: 834–841
  8. Brauner R, Thibaud E, Bischof P, Sizonenko PC, Rappaport R (1985) Long-term results of GnRH analogue (Buserelin) treatment in girls with central precocious puberty. Acta Pediatr Scand 74: 945–951
  9. Buckler JMH (1984) Skeletal age changes in puberty. Arch Dis Child 59: 115–119
  10. Clayton RN, Harwood JP, Catt KJ (1979) Gonadotropin releasing hormone analogue binds to luteal cells and inhibits progesterone production. Nature 282: 90–92
  11. Clayton RN, Huhtaniemi IT (1982) Absence of gonadotropin releasing hormone receptors in human gonadal tissue. Nature 299: 56–59
  12. Crowley WF, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB (1981) Therapeutic use of pituitary desensitization with a long acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 52: 370–372
  13. Crowley WF, Filicori M, Spratt DI, Santoro NF (1985) The physiology of gonadotropin releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 41: 473–531
  14. Evans RM, Doelle GC, Alexander AN, Uderman HD, Rabin D (1984) Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men. J Clin Endocrinol Metab 58: 862–867
  15. Fonzo D, Angeli A, Sivieri R, Andriolo S, Frajria R, Cesera F (1977) Hyperprolactinemia in girls with idiopathic precocious puberty under prolonged treatment with cyproterone acetate. J Clin Endocrinol Metab 45: 164–168
  16. Graf KJ, Schmidt-Gollwitzer M, Koch UJ, Lorenz F, Hammerstein J (1978) Hyperprolactinemia induced by cyproterone acetate in human subjects. J Endocrinol Invest [Suppl 215] 87: 96
  17. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford
  18. Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, Vainsel M (1985) Somatomedin C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab 61: 152–159
  19. Heather JD, Whitehead SA (1985) Changes in pituitary responsiveness to LH-releasing hormone after acute Buserelin treatment: a time-course and dose-dependent study. J Endocrinol 106: 27–30
  20. Holland FJ, Fishman L, Costigan DC, Luna L, Leeder S (1986) Pharmacokinetic characteristics of the gonadotropin-releasing hormone analogd-ser-(TBU)6-EA10 luteinizing hormone-releasing hormone (Buserelin) after subcutaneous and intranasal admidnistration in children with central precocious puberty. J Clin Endocrinol Metab 63: 1065–1070
  21. Hsueh AJW, Jones PBC (1981) Extra-pituitary actions of gonadotropin releasing hormone. Endocr Rev 2: 437–452
  22. Kauli R, Pertzelan A, Prager-Lewin R, Grunebau M, Laron Z (1976) Cyproterone acetate in treatment of precocious puberty. Arch Dis Child 51: 202–208
  23. Kauli R, Pertzelan A, Ben Zeev Z, Prager-Lewin R, Kaufman H, Comaru Schally AM, Schally AV, Laron Z (1984) Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate. Further experience. Clin Endocrinol 20: 377–387
  24. Knobil E (1980) The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 36: 53–88
  25. Lee PA (1981) Medroxyprogesterone therapy for sexual precocity in girls. Am J Dis Child 135: 443–447
  26. Luder AS, Holland FJ, Costigan DC, Jenner MR, Wielgosz G, Fazekas ATA (1984) Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 58: 966–972
  27. Mann DR, Gould KH, Collins DC (1984) Influence of continous gonadotropin-releasing hormone (GnRH) agonist treatment on luteinizing hormone and testosterone secretion, the response to GnRH, and the testicular response to human chorionic gonadotropin in male rhesus monkeys. J Clin Endocrinol Metab 58: 262–267
  28. Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF (1983) Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation. N Engl J Med 309: 1286–1290
  29. Pieper DR, Richards JS, Marshall JC (1981) Ovarian gonadotropin releasing hormone (GnRH) receptors: characterization, distribution and induction by GnRH. Endocrinology 108: 1148–1155
  30. Reznik Y, Winiger BP, Aubert ML, Sizonenko PC (1984) Pharmacodynamics of [Desgly10,d-Ser (t-Bu)6]-GnRH-EA in 6 normal volunteers and in 2 girls with precocious puberty. Pediatr Res 182: 1210 (abstr)
  31. Rudlin CR, Mansfield MJ, Crigler JF, Karol KA, Crawford JD, Boepple PA, Crowley WF (1985) Decrease in growth hormone and somatomedin C during LHRH agonist treatment of central precocious puberty. Pediatr Res 19: 633 (abstr)
  32. Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M, Francois R, Garandeau P, Lahlou N, Morel Y, Schally AV (1986) Long-term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-TRP6-luteinizing hormone-releasing hormone microcapsules. J Clin Endocrinol Metab 62: 670–677
  33. Sandow J (1983) Clinical applications of LHRH and its analogues. Clin Endocrinol 18: 571–592
  34. Sandow J, Rechenberg WV, Baeder C, Engelbart K (1980) Antifertility effects of an LHRH analogue in male rats and dogs. Int J Fertil 25: 213–221
  35. Schaison G, Brailly S, Vuagnat P, Bouchard P, Milgrom E (1984) Absence of direct inhibitory effect of the GnRHd-Ser (TBU)6, Desgly-NH210 GnRH ethylamide (Buserelin) on testicular steroidogenesis in men. J Clin Endocrinol Metab 58: 885–890
  36. Schurmeyer TH, Knuth UA, Freischem CW, Sandow J, Bint Akhtar F, Nieschlag E (1984) Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion. J Clin Endocrinol Metab 59: 19–24
  37. Smith R, Donald RA, Espiner EA Stronach S (1979) The effects of prolonged administration ofd-SER (TBU)6-LHRH-EA10 (HOE 766) in subjects with hypogonadotropic hypogonadism. Clin Endocrinol 11: 553–559
  38. Stanhope R, Adams J, Brook CGD (1985) The treatment of central precocious puberty using an intranasal LHRH analogue (Buserelin). Clin Endocrinol 26: 795–806
  39. Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM (1985) Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography and the hypothalamic-pituitary-gonadal axis. J Clin Endocrinol Metab 61: 142–151
  40. Tanner JM (1962) Growth at adolescence, 2nd ed. Blackwell, Oxford
  41. Tanner JM, Whitehouse RH, Takaishi M (1965) Standards from birth to maturity for height, weight, height velocity and weight velocity: British children 1965. Arch Dis Child 41: 454–471
  42. Tanner JM, Goldstein H, Whitehouse RH (1970) Standards for children’s height at ages 2–9 years allowing for height of parents. Arch Dis Child 45: 755–762
  43. Tanner JM, Whitehouse RH, Marshall WA, Healy MJR, Goldstein H (1975) Assessment of skeletal maturity and prediction of adult height. Academic Press, London New York
  44. Tanner JM, Landt KW, Cameron N, Carter BS, Patel J (1983) Prediction of adult height from height and bone age in childhood. A new system of equations (TW mark II) based on a sample including very tall and very short children. Arch Dis Child 58: 767–776
  45. Werder Edmond A, Mürset Gertrud, Zachmann Milo, Brook Charles G D, Prader Andrea, Treatment of Precocious Puberty with Cyproterone Acetate, 10.1203/00006450-197404000-00006
  46. Wierman ME, Beardsworth DE, Crawford JD, Crigler JF, Mansfield MJ, Bode HH, Boepple PA, Kushner DC, Crowley WF (1986) Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche. J Clin Invest 77: 121–126
  47. Wallach Edward E., Yen Samuel S.C., Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs**Supported in part by NIH HD12303, NIH contract, PARFR-228, and conducted in part with the support of the Clayton Foundation for Research, California Division., 10.1016/s0015-0282(16)46869-x
  48. Zachmann M, Sobradillo B, Frank M, Frisch H, Prader A (1978) Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions. J Pediatr 93: 749–755